Abbott
How big pharma is focusing on diversity, equity and inclusion
November 11 by Leila HawkinsAs Bayer tops list for DEI efforts, we look at how this impacts clinical research
Meet Pharma IQ’s advisory board: Jennifer Jones-McMeans
October 07 by Leila HawkinsWe speak to Pharma IQ board member Jennifer Jones-McMeans about making clinical trials accessible to underserved communities
Driving diversity in clinical trials
March 21 by Leila HawkinsPharma IQ speaks to Abbott Vascular about making sure clinical trials are diverse and inclusive
Keeping tabs on Covid-19: Pharma IQ’s top four coronavirus news stories of 2020
December 23 by Emily UwemedimoRead our editor’s top picks of 2020 from Pharma IQ’s Keeping tabs on Covid-19 series
Keeping tabs on Covid-19: Five-dollar antigen test, next-gen Covid-19 vaccine prospect and therapeutic program for patients with respiratory distress
August 28 by Emily UwemedimoDiscover the novel ways biotech and pharma companies are collaborating to collectively respond to improve Covid-19 outcomes
Keeping tabs on Covid-19: Glucose monitoring technology donations, clinical pharmacology principles for vaccine developed, scaling viral vector-based vaccines scaled
June 12 by Emily UwemedimoExplore new strategies in health for helping individuals deal with social and physical distancing during the Covid-19 pandemic
Gamification: Why health wins
August 05 by Pharmaceuticals & Biotechnology EditorAbbott’s pharmaceutical business takes a look at how gamification can lead to improvements in healthcare.
The Top 10 Biggest Pharmaceutical Companies: Who's Recruiting? - Updated
December 11 by Gerald ClarkeWith many economies worldwide now recovering from the global financial crisis, we attempt to gauge pharma’s recovery. So which organisations are announcing new plant investments and recruitmen...
How to Avoid Common Pitfalls in the Design of Medical Interfaces
March 23 by Andrea CharlesHuman factors principles and practices are playing an increasingly important role in medical device design as manufacturers recognise the range of benefits. In this interview Dr. Edmond W Israelski,...
Current Challenges and Future Developments for Drug Safety in Emerging Markets
October 14 by Pharmaceuticals & Biotechnology EditorGetting a Headstart in Human Factor Principles with HE75
April 26 by Edmond IsraelskiIn this interview Dr. Edmond W Israelski, Director, Human Factors, Abbott Quality and Regulatory, Abbott, joins Andrea Charles from Pharma IQ, shares his top tip for successfully applying...
Sindusfarma's Jair Calixto on Shipping Temperature Control Products into Latin America
April 26 by Pharmaceuticals & Biotechnology EditorSindusfarma is the first business association in the São Paulo State’s pharmaceutical industry. Established in April 26, 1933 by a group of idealists in order to defend the interests of...